lgnd: the income statement

MyFinsight

LIGAND PHARMACEUTICALS INC (LGND)

For the year ending 2024-12-31, LGND made $83,079K in revenue. -$4,032K in net income. Net profit margin of -4.85%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2024-12-31
Income tax expense	6,550
Operating income (loss) from continuing operations	-22,606
Other non-operating (expense) income, net	-54,918
Interest income	8,055
Interest expense	3,037
Gain from short-term investments	75,024
Total non-operating income, net	25,124
Income before income tax from continuing operations	2,518
Net income (loss) from continuing operations	-4,032
Net income (loss)	-4,032

Basic eps	-0.22
Diluted eps	-0.22
Basic average shares	18,290,000
Diluted average shares	18,290,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)